Literature DB >> 28151558

Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes.

Kohei Hosokawa1, Sachiko Kajigaya1, Keyvan Keyvanfar1, Wangmin Qiao2, Yanling Xie2, Angelique Biancotto3, Danielle M Townsley1, Xingmin Feng1, Neal S Young1.   

Abstract

The aetiology of paroxysmal nocturnal haemoglobinuria (PNH) is a somatic mutation in the X-linked phosphatidylinositol glycan class A gene (PIGA), resulting in global deficiency of glycosyl phosphatidylinositol-anchored proteins (GPI-APs). This study applied RNA-sequencing to examine functional effects of the PIGA mutation in human granulocytes. CXCR2 expression was increased in GPI-AP- compared to GPI-AP+ granulocytes. Macrophage migration inhibitory factor, a CXCR2 agonist, was significantly higher in plasma of PNH patients. Nuclear factor-κB phosphorylation was upregulated in GPI-AP- compared with GPI-AP+ granulocytes. Our data suggest novel mechanisms in PNH, not obviously predicted by decreased production of the GPI moiety.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  CXCR2; RNA-sequencing; paroxysmal nocturnal haemoglobinuria

Mesh:

Substances:

Year:  2017        PMID: 28151558      PMCID: PMC5378616          DOI: 10.1111/bjh.14502

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient.

Authors:  J Ratajczak; M Kucia; K Mierzejewska; R Liu; C H Kim; N Natarajan; V Sharma; D M Miller; J Maciejewski; M Z Ratajczak
Journal:  Leukemia       Date:  2012-02-20       Impact factor: 11.528

Review 2.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young; Rodrigo T Calado; Phillip Scheinberg
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

3.  The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.

Authors:  Remo C Russo; Cristiana C Garcia; Mauro M Teixeira; Flavio A Amaral
Journal:  Expert Rev Clin Immunol       Date:  2014-03-29       Impact factor: 4.473

4.  MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.

Authors:  Jürgen Bernhagen; Regina Krohn; Hongqi Lue; Julia L Gregory; Alma Zernecke; Rory R Koenen; Manfred Dewor; Ivan Georgiev; Andreas Schober; Lin Leng; Teake Kooistra; Günter Fingerle-Rowson; Pietro Ghezzi; Robert Kleemann; Shaun R McColl; Richard Bucala; Michael J Hickey; Christian Weber
Journal:  Nat Med       Date:  2007-04-15       Impact factor: 53.440

5.  CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection.

Authors:  Hakim Echchannaoui; Karl Frei; Maryse Letiembre; Robert M Strieter; Yoshiyuki Adachi; Regine Landmann
Journal:  J Leukoc Biol       Date:  2005-06-07       Impact factor: 4.962

Review 6.  The interleukin-8 pathway in cancer.

Authors:  David J J Waugh; Catherine Wilson
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

7.  Individual hematopoietic stem cells in human bone marrow of patients with aplastic anemia or myelodysplastic syndrome stably give rise to limited cell lineages.

Authors:  Takamasa Katagiri; Hiroshi Kawamoto; Takashi Nakakuki; Ken Ishiyama; Mariko Okada-Hatakeyama; Shigeki Ohtake; Yu Seiki; Kohei Hosokawa; Shinji Nakao
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

8.  Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells.

Authors:  R J Johnson; A C Rawstron; S Richards; G J Morgan; D R Norfolk; S O Hillmen
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

9.  Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria.

Authors:  Wenyi Shen; Michael J Clemente; Naoko Hosono; Kenichi Yoshida; Bartlomiej Przychodzen; Tetsuichi Yoshizato; Yuichi Shiraishi; Satoru Miyano; Seishi Ogawa; Jaroslaw P Maciejewski; Hideki Makishima
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

10.  CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells.

Authors:  Amy Sinclair; Laura Park; Mansi Shah; Mark Drotar; Simon Calaminus; Lisa E M Hopcroft; Ross Kinstrie; Amelie V Guitart; Karen Dunn; Sheela A Abraham; Owen Sansom; Alison M Michie; Laura Machesky; Kamil R Kranc; Gerard J Graham; Francesca Pellicano; Tessa L Holyoake
Journal:  Blood       Date:  2016-05-24       Impact factor: 22.113

View more
  2 in total

1.  Host and Parasite Transcriptomic Changes upon Successive Plasmodium falciparum Infections in Early Childhood.

Authors:  Katie R Bradwell; Drissa Coulibaly; Abdoulaye K Koné; Matthew B Laurens; Ahmadou Dembélé; Youssouf Tolo; Karim Traoré; Amadou Niangaly; Andrea A Berry; Bourema Kouriba; Christopher V Plowe; Ogobara K Doumbo; Kirsten E Lyke; Shannon Takala-Harrison; Mahamadou A Thera; Mark A Travassos; David Serre
Journal:  mSystems       Date:  2020-07-07       Impact factor: 6.496

2.  Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation.

Authors:  Kerstin Pohl; David P Nichols; Jennifer L Taylor-Cousar; Milene T Saavedra; Matthew J Strand; Jerry A Nick; Preston E Bratcher
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.